Post by Gilead Sciences on X
Gilead Sciences@GileadSciences
X#GileadNews: The U.S. FDA approves first and only single-tablet regimen for the treatment of HIV in adults who are virologically suppressed, including those on complex multi-tablet regimens. Learn more: t.co
26 likes2 repliesPosted Aug 27, 2026